In this review, we examine the state-of-the-art technologies (gas and liquid chromatography, mass spectroscopy and nuclear magnetic resonance, etc.) in the well-established area of metabolomics especially as they relate to protozoan parasites.
Introduction
In the 19th and first 80 years of the 20th century when an organism's metabolic pathways were being investigated, some assumptions about what pathways may or may not be present in the organism were made and where possible, coupled to the use of radiolabeled precursors to look for labeled end products often separated and identified by chromatography. These experiments were followed by or coupled with assaying for enzymes involved in the pathway(s) using methodologies developed for similar pathways in other organisms. Although successful, this approach did not allow the discovery of new pathways.
Leaping forward into the late 20th and early 21st centuries, we come to the age of genomics -the determination of an organism's complete DNA sequence with genetic mapping. Various genome projects have begun and many have been completed. In a similar attempt to catalogue gene products, 'proteomics' became fashionable and a study of the organism's entire protein complement, especially their structure and function, was undertaken.
With an organism's genome and proteome completed, it would seem that an accurate prediction of an organism's metabolic pathways could be made. However, even with genomic, mRNA expression (transcriptomics) and proteomics data, it is not always possible to understand the whole story of a cell's metabolic capacity, especially since not all genes in a genome are expressed necessarily during the cell's entire cycle or during an organism's developmental stages. Similarly, if a gene is not expressed then that gene's product will not be expressed, and if that product is an enzyme, then the metabolite of that enzyme will not be produced. Metabolites are metabolic intermediates and end products, often considered 1 kDa or less in mass, and determining those present represents a metabolic profile showing a snap shot of a cell's physiology at a given time-termed the 'metabolome' and its characterization -termed 'metabolomics' (Nicholson et al. 1995; Kafsack and Llinas 2010) . With this knowledge and the technological ability to examine a cell's complete metabolite complement, a new field of study, termed metabolomics that delineates all the metabolites in a given cell, tissue, organ or organism (Jordan et al. 2009 ) at any given time, has developed.The analytical technologies employed in metabolomics include separation and detection technologies: separation technologies include high performance liquid (HPLC), gas chromatography (GC) and capillary electrophoresis (CE) while detection technologies include mass spectrometry (MS) and other spectroscopies including nuclear magnetic resonance (NMR) spectroscopy. MS is often linked to the chromatographic separation devises such as GC-MS or HPLC-MS.
A recent news feature brought to the forefront the various 'omics' that now seem to proliferate in the world of cell and molecular biology (Baker 2013) . Although this feature is a lighthearted account of how the term 'omics' has proliferated and has been applied to a range of esoteric analyses, it does highlight those that have a significant role in expanding our knowledge of cell and tissues biology. The article also highlights the integration of the vast amounts of data generated by Timothy Paget et al. 128 these 'omics' is the way forward in there use and this will greatly improve our understanding of metabolic and cellular capacity of cells and tissue. In this review, we examine the state-of-the-art in the well-established area of metabolomics especially as they relate to protozoan parasites.
Technology
Whether prokaryotic or eukaryotic, cells contain a wide variety of molecules such as sugars, organic acids, amino acids and lipids (Roux et al. 2011) (Shulaev 2006) . Therefore, a combination of extraction protocols and analytical platforms are often used depending upon the type of metabolomic study undertaken (fingerprinting, profiling or targeted) and the associated metabolite's chemical structures that is under investigation. The most common techniques used in metabolomics alongside their advantages and limitations are shown in Table I . Of these, the two analytical methods primarily used to study metabolomes are NMR and MS.
NMR, a non-destructive and highly reproducible spectroscopic technique, requires minimal sample preparation, can be automated easily and involves mixing the sample with a minimum of 10% D 2 O containing a reference for chemical shift and quantification (e.g., deuterated sodium trimethylsilyl propionate-d4 [TSP-d4] or 2, 2-dimethyl-2-silapentane-5-sulfonic acid-d6 ). The analysis time is on the order of a few minutes and as such, is well suited for high throughput applications. NMR spectroscopy allows the study of several nuclei:
1 H, 31 P and 13 C. Given the low natural abundance of the 13 C isotope, enriched culture media are commonly used in targeted metabolomic studies and can give valuable information on a specific metabolic pathway. Like the 1 H nucleus,
31
P is present at 100% natural abundance and is well suited for the specific study of energetic fluxes and metabolism within cells. NMR is a universal technique since it can detect all proton-containing analytes unlike MS, which is limited to a class of chemical structures depending on the ionization source and instrument used. The major drawback of NMR is its low sensitivity (μM) when compared to MS that can usefully detect small molecules at concentrations as low as pM. In addition, NMR analysis of complex samples results in crowded spectra and many overlapped signals thus limiting the identification of individual metabolites.
Magic Angle Spinning (MAS) technology allows the analysis of intact tissue sample without any pre-treatment, except the addition of D 2 O (Lindon et al. 2005) . The sample is spun at ca. 3 kHz at an angle of 54.7° to the direction of the applied magnetic field in order to remove the line broadening effects due to dipolar interactions and susceptibility differences within the sample resulting in high resolution quality spectra. Therefore, the MAS approach enables many other di- 
Application to cellular systems
The application of technologies such as NMR and MS to the study of cellular metabolic process has renewed interest in this area of cell biology. If one uses publication data from the National Institutes of Health's PubMed (http://www.ncbi.nlm.nih. gov/pubmed), one can see that since 2000 there have been nearly 10,000 publications on the applications of metabolomics: for human systems the number approaches 2400, for cellular systems it is approximately 1400, for cancer 700 and for the identification of biomarkers 1000. Metabolomics is being used to identify changes associated with many major chronic states such as cancer, diabetes, cardiovascular disease and to unlock key aspects of metabolism in specific organs such as the kidney, liver and heart. Meng et al. (2013) describes how metabolomics along with other approaches such as epigenomics, transcriptomics, proteomics and metabolomics allows for the identification and visualization of specific perturbations in critical biological processes associated with obesity, diabetes, and cardiovascular diseases. An expanding application of this technology is in the area of drug discovery; the pharmaceutical industry is already using this for target identification, validation and toxicological analysis. With improvements in the speed at which metabolomic data can be generated and the possibility of high throughput technology this is likely to become a standard tool for the pharmaceutical industry (Russell et al. 2013) .
The interaction of these technologies with isotopic labeling techniques and computational methodologies has opened up new areas of research and allowed the development of highly accurate metabolic flux models of cell and tissue metabolism (Maier et al. 2008; Shimizu 2004) . Linking these types of data to those obtained from gene and protein expression generates an overall picture of metabolic regulation in several cell and tissue types.
The potential of metabolomics has been demonstrated on a number of neurological disorders, various cancers such as invasive prostate cancer (i.e. sarcosine) and colorectal cancer (fatty acids), cardiological abnormalities and other common disease such as diabetes (diabetic glucose levels) (Nevedomskaya 2011; Creek et al. 2012) . Metabolomic analysis has also been applied widely to study the systems biology of numerous model organisms across the tree of life, including Archeae (Trauger et al. 2008) , Eubacteria, (Rabinowitz 2007) , Fungi, (Brauer et al. 2006) , plants (Cho et al. 2008; Lisec et al. 2008) , animals (Pedersen et al. 2008; Sun et al. 2007) , and human cell tissue culture (Khoo and Al-Rubeai 2007) .
Application to protozoan parasite systems
Parasitological research has benefited from recent advances in analytical technologies applied to profiling biological extracts or samples obtained from the parasite and host organisms. The application of post-genomic technologies (transcriptomics, proteomics, lipidomics and metabolomics) in parasitology has opened many avenues for deepening our understanding of parasite biology and of host-parasite interactions. By judicious integration of 'omic' technologies with mathematical modeling and bioinformatics tools, we should be able to translate new mechanistic knowledge into practical solutions to control and treatment of parasitic infections and to combat developing drug resistance (Holmes 2010; Lakshmanan et al. 2011) .
To understand fully the phenotypic characteristics of an organism, it is essential to complement transcriptome and proteome data with metabolomics investigations. Metabolomic studies are carried out because they offer the closest representation of the phenotype when compared to the genes. Also, they contain more valuable information on disease development while genetics only give insight into predisposition to a disease. A metabolomic study identifies and quantifies the complement of small-molecule metabolites (including metabolic intermediates and secondary metabolites) in a biological sample. Cellular physiology impact on the steady state levels of metabolites, metabolic dynamics, and measurements of the metabolome can be used to detect subtle changes in a biological system . Most physiological functions are carried out at this level, making the metabolome the closest correlate to the phenotype. Metabolite levels are not easily predicted due to the highly non-local control structure of the metabolic network (e.g. enzyme inhibitors functioning at distant points in the metabolic network), and hence require separate investigation (Scheltema et al. 2010) . Thus, metabolomics has emerged as a key area in biomarker discovery .
More recently metabolomics has been used to study trypanosomatid in particular the biology of this parasite and aspects of host parasite interactions (Kafsack and Llinas 2010) . Metabolic studies have been carried out in Leishmania (Creek et al. 2011; Scheltema et al. 2010) and Trypanosoma (Vincent et al. 2012; Creek et al. 2011) . Additional studies have been performed on Plasmodium (Besterio et al. 2010; Laksmanan et al. 2011 ). However, we use studies on Entamoeba to show how metabolomics can be used to assess key aspects of metabolism in this parasite. Husain et al. (2010) used metabolomics to study effect of L-cysteine on E. histolytica. This work revealed S-methylcysteine levels and phosphatidylisopropanolamine synthesis increased. L-cysteine is an essential component playing a role in proliferation, adherence and defense mechanism against oxidative stress and hence its deprivation led to the increased intermediate components which in turn repressed glycolysis and energy generation. Jeelani et al. (2012) used CEMS and DNA microarray-based expression to investigate metabolic and transcriptomic changes that occur during encystation in Entamoeba invadens, a relative of E. histolytica from reptiles but unlike E. histolytica, will encyst in in vitro culture. As encystations progressed, the levels of a majority of metabolites involved in glycolysis and nucleotides decreased markedly, indicating energy generation ceases. Also, the flux of glucose utilization shifted from energy production to chitin wall biosynthesis. There was a temporal increase in isoamylamine, isobutylamine, and cadaverine, during the early period of encystation, when the trophozoites form large multicellular aggregates (precyst), and there was an induction of γ-aminobutyric acid (GABA).
We can compare the above data to those obtained for Giardia over a period of more than 20 years using 14C-labeling and enzymes assays to assess metabolic activity. Lindmark et al. (2011) reviewed these data especially as they relate to carbohydrates and from this the authors hypothesized that during encystment, there is a shift in carbohydrate utilization from glycolysis to cyst wall carbohydrate (giardan) formation and that energy production comes primarily from the arginine dihydrolase pathway during this process. Interestingly, proteomics has helped in supporting this hypothesis; however, this work still remains to be completed and it is clear that a metabolomics approach is now required to really identify changes in metabolic flux during encystment.
These studies highlight the use of metabolomics in various aspects such as understanding the pathways of drug action and studying the levels of intracellular metabolites during various life processes that address key issues such as diagnostics, metabolism and the mechanism of action of drugs that kill these parasites (Creek et al. 2011) . With the increasing need for better anti-parasitic drugs and diagnostics, metabolomics is proving to be a valuable tool not only in the identification of potential drug targets and defining markers of infection but also identifying the mechanisms of action of drugs (Nevedomskaya et al. 2011) .
Where do we go next ?
Metabolomics like the other 'omics' is a powerful tool in the armory of researchers and may help in elucidating novel aspects of parasite and vector biology and is also likely to provide key insights into the biochemistry of the host-parasite interaction. It is also likely to help in the identification of species-specific and infection state biomarkers that correlate with various clinical manifestations or disease progression (Laksmanan et al. 2011) . With the recent advances in methodologies for measuring complex mixtures of cellular biomolecules, metabolomic studies of parasites hold great promise for the improved understanding and control of protozoan parasites. Various important applications can be explored include parasitic metabolic requirements during differentiating life stages or even following transmission into a new host species. In turn, host responses to parasite infection in terms of how parasites siphon energy and metabolites from the host and how the host can modify its metabolism to combat the parasite infection can also be studied at metabolic levels (Laksmanan et al. 2012) . Several workers have already used metabolomics coupled with computer based modeling to help delineate such interactions.
Another interesting question is the dissection of potentially non-canonical biochemical pathways and of parasite specific metabolism (Kafsack and Llinas 2010; Besterio et al. 2010) . Additionally, metabolomics helps in the identification of potential drug targets, defining markers of infection and the characterization of novel drug effects on host and parasite metabolite levels, promising identification of their mechanisms of action. Hence metabolomics allows (1) profiling the metabolite dynamics associated with the (and often unknown) mode of action of effective anti-parasitic drugs and (2) profiling the adapted metabolism of drug-resistant parasites (Kafsack and Llinas 2010). Likely, this field will foster the development of improved drugs and better control measures, the discovery of more effective vaccine candidates and facilitate the translation of this knowledge into new chemotherapy (Lakshmanan et al. 2011) .
